Plain-English translation of NCT06866444 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Duloxetine is an FDA-approved medication that helps many people with fibromyalgia, but it works much better for some patients than others. This research study wants to understand why by looking at your genes and measuring how much of the medication stays in your bloodstream. By understanding these differences, doctors may eventually be able to predict which patients will benefit most from this treatment.
Even though this medication is proven to help fibromyalgia, there's a wide range in how well it works from person to person. Some people get great relief while others see little improvement. Researchers believe differences in how your body processes the medication — based on your genes — may explain this. If they can identify who will and won't respond well, doctors could make better treatment choices from the start and avoid wasting time on medications that won't help.
You likely qualify if…
You likely don't qualify if…
As a participant, you would continue taking the medication you're already on at your current dose. The study involves answering questions about your fibromyalgia symptoms using a standard questionnaire and having your blood drawn so researchers can measure how much medication is in your system and test your genes. This is a feasibility study designed to work out the details before a larger research effort begins.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States